# EDGAR Filing Document

**Accession Number:** 0000941221
**File Stem:** 0001178913-26-001908
**Filing Date:** 2026-3
**Character Count:** 5662
**Document Hash:** a1bbd4985837b6592062a7d3f63a8661
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-26-001908.hdr.sgml**: 20260330

**ACCESSION NUMBER**: 0001178913-26-001908

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260318

**FILED AS OF DATE**: 20260330

**DATE AS OF CHANGE**: 20260330

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Geva Harel Lilach
- **CENTRAL INDEX KEY:** 0002115658

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13742
- **FILM NUMBER:** 26815728

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 23 ARANHA ST.
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3
- **ZIP:** 6120201
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ICL Group Ltd.
- **CENTRAL INDEX KEY:** 0000941221
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** MILLENNIUM TOWER
- **STREET 2:** 23 ARANHA STREET, P.O. BOX 20245
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** (972-3) 684-4400

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** MILLENNIUM TOWER
- **STREET 2:** 23 ARANHA STREET, P.O. BOX 20245
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISRAEL CHEMICALS LTD
- **DATE OF NAME CHANGE:** 19950314

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Geva Harel Lilach<br><sub>(Last) (First) (Middle)</sub><br>C/O ICL GROUP LTD.<br>MILLENNIUM TOWER, 23 ARENHA ST.<br><sub>(Street)</sub><br>TEL AVIV, ISRAEL 6120201<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>ICL Group Ltd. [ ICL ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Deputy Chief Executive Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to Buy) | <sup>(1)</sup> | 2027-02-08 | Ordinary Shares | 649180 | 9.39<sup>(4)</sup> | D<sup>(5)</sup> |  |
| Stock Options (Right to Buy) | <sup>(2)</sup> | 2029-04-04 | Ordinary Shares | 984095 | 5.87<sup>(6)</sup> | D<sup>(5)</sup> |  |
| Stock Options (Right to Buy) | <sup>(3)</sup> | 2030-12-07 | Ordinary Shares | 416667 | 5.91<sup>(7)</sup> | D<sup>(5)</sup> |  |

---

### Footnotes:

(1) The stock options are fully vested and exercisable.

(2) The stock options vest in three equal annual installments from the April 4, 2024, grant date.

(3) The stock options vest in three equal annual installments from the December 7, 2025, grant date.

(4) Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

(5) The options are held by a Trustee in the name of the Reporting Person.

(6) Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

(7) Represents an exercise price of NIS 18.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

**Signature:** /s/ Geva Harel Lilach  
**Date:** 2026-03-30

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**